UBE Corporation FY2027 Q1 Earnings Report

Quick View

Executive Summary

The current period achieved substantial revenue growth and an increase in operating income; however, net income remained roughly at the previous-year level due to extraordinary losses and a high tax burden. Revenue was ¥1219.0B (+21.3% YoY), operating income was ¥55.5B (+88.6%), and ordinary income was ¥112.5B (+81.5%), representing significant improvements. Meanwhile, net income attributable to owners of the parent declined to ¥41.9B (-3.9%), while consolidated net income was ¥45.8B (+0.4%), remaining essentially flat. The primary drivers of revenue growth were the rapid expansion of the Urethane Business through M&A and a recovery in demand for Polymers&Chemicals, while the increase in earnings was attributable to an improved gross margin and higher equity-method investment income.

Factors Affecting Financial Performance

【Revenue】Revenue increased substantially to ¥1219.0B, up +21.3% YoY. By segment, PolymersAndChemicals remained the largest segment at ¥654.9B (53.7% composition ratio, YoY +11.0%), while HighPerformanceUrethans expanded rapidly to ¥157.1B (+397.0%) due to the impact of its conversion into a subsidiary. SpecialtyProducts grew to ¥205.8B (+18.0%), while Machinery posted a slight revenue decline to ¥141.1B (-2.8%).

【Profit and Loss】Operating income increased substantially to ¥55.5B (+88.6% YoY). The gross margin improved to 23.7% from 17.6% in the previous year, absorbing an increase in SG&A expenses (¥233.7B, +27.0%). By segment, SpecialtyProducts was the largest earnings contributor at ¥32.4B (15.7% margin), while PolymersAndChemicals continued to have a low-margin structure, generating ¥26.5B (4.0% margin). Pharmaceutical posted an operating loss of ¥-5.0B. Ordinary income was ¥112.5B (+81.5%), substantially exceeding operating income, supported by non-operating income including ¥54.1B in equity-method investment income and ¥9.7B in foreign exchange gains. Meanwhile, net income attributable to owners of the parent declined slightly to ¥41.9B (-3.9%), due to the recognition of ¥15.1B in extraordinary losses and a high tax burden of ¥53.4B in income taxes and other taxes (a burden ratio of 53.8% relative to profit before tax). Although revenue and operating and ordinary income increased, the Company did not achieve growth in final net income because of extraordinary losses and the tax burden.

Segment Analysis

SpecialtyProducts was the Company’s largest source of earnings, with segment profit of ¥32.4B (15.7% margin, YoY +69.2%), demonstrating a further improvement in profitability from the previous year. PolymersAndChemicals is the core business, accounting for 53.7% of the revenue mix, but has a low-margin structure, with operating income of ¥26.5B and a 4.0% margin, diluting the Company-wide margin. HighPerformanceUrethans expanded rapidly, with revenue increasing +397.0% following its conversion into a subsidiary, but its margin remained at 3.9%, a level associated with the initial stage of integration. Machinery maintained relatively stable profitability with a 7.7% margin, while Pharmaceutical remained a burden on the Company, posting an operating loss of ¥-4.96B and a margin of -10.5%.

Key Financial Indicators

【Profitability】The operating margin improved to 4.6% from 2.9% in the previous year, while the ordinary income margin was 9.2%, substantially exceeding the operating level, indicating that non-operating factors such as equity-method investment income and foreign exchange gains boosted ordinary income. ROE remained low at 1.0%. Income taxes and other taxes of ¥53.4B against profit before tax of ¥99.2B represented a heavy tax burden, weighing on net income.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥225.6B, approximately five times net income, indicating exceptionally strong cash conversion.【Investment Efficiency】The equity ratio remained stable at 48.6%.【Financial Soundness】Liquidity was secured, with current assets of ¥3217.7B against current liabilities of ¥2008.9B. Although interest-bearing debt, comprising long-term borrowings of ¥1839.9B and bonds of ¥700.0B, was substantial, the presence of cash and deposits of ¥653.0B indicates no significant near-term concern regarding funding.

Cash Flow Analysis

Operating Cash Flow (OCF) increased +8.1% YoY to ¥225.6B, demonstrating strong cash-generation capacity equivalent to approximately five times net income of ¥45.8B. This was supported by improved working capital arising from a decrease in trade receivables (+¥60.6B) and an increase in trade payables (+¥92.5B). In contrast, an increase in inventories (-¥60.9B) was a negative factor for cash generation. Investing Cash Flow was positive at +¥131.7B, as inflows from asset sales and other sources exceeded capital expenditures. Financing Cash Flow was significantly negative at -¥266.9B, reflecting continued cash outflows from the reduction of short-term borrowings and dividend payments. As a result, free cash flow was substantially positive at ¥357.3B, indicating generally strong cash generation during the current period. However, part of the working capital improvement was accompanied by an increase in inventories, and attention should be paid to potential reversals from the following period onward.

Earnings Quality

During the current period, ordinary income substantially exceeded operating income, with the primary drivers of the difference being non-operating income such as ¥54.1B in equity-method investment income and ¥9.7B in foreign exchange gains. These factors are separate from the earning power of the core business. Although growth in ordinary income (+81.5%) was similar in scale to growth in operating income (+88.6%), the qualitative difference should be noted. In addition, extraordinary losses of ¥15.1B were recognized, while extraordinary gains were limited to ¥1.8B in gains on sales of property, plant and equipment, with the difference weighing on final net income. Income taxes and other taxes of ¥53.4B represented 53.8% of profit before tax of ¥99.2B. The effective tax rate increased from the previous year and was the primary reason that net income attributable to owners of the parent failed to keep pace with growth at the operating and ordinary income levels. Comprehensive income was ¥77.2B, exceeding net income of ¥45.8B, with additional gains from valuation of other securities, including ¥16.3B in foreign currency translation adjustments and ¥15.0B in valuation difference on available-for-sale securities.

Earnings Forecasts and Guidance

Against the full-year plan, revenue progress was 25.1% (revenue of ¥1219.0B / full-year ¥4850.0B), operating income progress was 23.6% (¥55.5B / ¥235.0B), and ordinary income progress was 30.0% (¥112.5B / ¥375.0B), generally in line with standard quarterly progress of approximately 25%. Ordinary income was slightly ahead of plan due to support from non-operating income, while operating income was almost exactly on the standard trajectory. The full-year plan calls for revenue growth of +4.9% and operating income growth of +24.1%, while ordinary income is planned to remain at the previous-year level (+0.0%). There were no revisions to the earnings forecast or dividend forecast during the current quarter.

Shareholder Returns

The annual dividend forecast is ¥160, representing a plan for a substantial increase from the previous-year dividend of ¥55 (partial data for the interim and year-end total). Based on the full-year net income plan of ¥245.0B and average shares outstanding during the period of 97.14 million shares, total annual dividends are estimated at approximately ¥155B, implying a payout ratio of approximately 63%. Share buybacks were only ¥0.0B during the current period, and shareholder returns are currently centered on dividends. There were no revisions to the dividend forecast during the current quarter.

Risk Factors

1. Concentration of earnings structure: PolymersAndChemicals accounts for 53.7% of the revenue mix but has a low 4.0% margin. The low profitability of the core business is a factor keeping the Company-wide operating margin at 4.6%, below the industry median of 8.7%.

2. High tax burden and extraordinary losses: Income taxes and other taxes reached 53.8% of profit before tax. Together with extraordinary losses of ¥15.1B, this creates a structure in which growth at the operating and ordinary income levels is less likely to be reflected in net income growth.

3. Goodwill and M&A integration risk: Revenue in the HighPerformanceUrethans segment expanded rapidly (+397.0%) following its conversion into a subsidiary, but its margin remained at 3.9%. The realization of integration benefits will determine future profitability.

Industry Benchmark (For Reference; Prepared by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company’s profitability is below the industry median, placing it at a relative disadvantage in terms of margins within the manufacturing industry.

Growth and Capital Efficiency

The revenue growth rate substantially exceeds the industry median, representing a top-tier growth pace within the industry, including the effects of M&A.

※Source: Prepared by the Company

Key Points from the Earnings Release

1. Growth in revenue and operating and ordinary income is clear, but net income remained roughly at the previous-year level. The fact that the high tax burden and extraordinary losses restrained growth in final net income is noteworthy when evaluating earnings quality.

2. Operating Cash Flow (OCF) reached approximately five times net income, indicating strong cash-generation capacity. However, part of the working capital improvement accompanied by an increase in inventories (-¥60.9B) may contain temporary factors, making subsequent trends a key point of attention.

3. In terms of segment mix, the expansion of SpecialtyProducts (15.7% margin) coexists with the low-margin structure of PolymersAndChemicals (4.0% margin). Changes in the composition ratio of higher-margin segments will be a key factor to monitor in determining the future trend of the Company-wide margin.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade period). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥4,206–¥4,444 at ±1% for the cost of equity, and ¥4,310–¥4,330 at ±0.1 for ω.

Notes:

• Goodwill amortization of ¥24.6 per share is added back to earnings (for non-cash expense and comparability with IFRS companies).
• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-07 / This value is not intended to predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---